Versant Venture Management as of Dec. 31, 2019
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crispr Therapeutics (CRSP) | 77.2 | $256M | 4.2M | 60.91 | |
| Veracyte (VCYT) | 10.1 | $34M | 1.2M | 27.92 | |
| Gritstone Oncology Ord (GRTSQ) | 8.4 | $28M | 3.1M | 8.97 | |
| Ocular Therapeutix (OCUL) | 2.6 | $8.8M | 2.2M | 3.95 | |
| Second Sight Med Prods | 1.0 | $3.3M | 4.5M | 0.74 | |
| Clovis Oncology | 0.3 | $1.1M | 102k | 10.43 | |
| Cymabay Therapeutics | 0.3 | $1.1M | 544k | 1.96 |
